CONJUPRI 2.5 MG Oral Tablet

RxCUI: 2377369
RxNorm name: CONJUPRI 2.5 MG Oral Tablet
Display name: CONJUPRI 2.5 MG Oral Tablet
Full name: CONJUPRI 2.5 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Conjupri	LEVAMLODIPINE	CSPC Ouyi Pharmaceutical Co. Ltd	c3cca66e-348a-43e8-8f96-e995104dae3d	2024-12-11	Warnings, Adverse reactions	Exact identifier rxcui: 2377369

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
c3cca66e-348a-43e8-8f96-e995104dae3d	Conjupri 2.5 MG Oral Tablet	SY	6	These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019	20241211
c3cca66e-348a-43e8-8f96-e995104dae3d	Conjupri 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral Tablet	SY	6	These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019	20241211
c3cca66e-348a-43e8-8f96-e995104dae3d	levamlodipine 2.5 MG Oral Tablet [Conjupri]	SBD	6	These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019	20241211
c3cca66e-348a-43e8-8f96-e995104dae3d	CONJUPRI 2.5 MG Oral Tablet	PSN	6	These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019	20241211
f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4	CONJUPRI 2.5 MG Oral Tablet	PSN	2	These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019	20220503
f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4	Conjupri 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral Tablet	SY	2	These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019	20220503
f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4	levamlodipine 2.5 MG Oral Tablet [Conjupri]	SBD	2	These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019	20220503
f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4	Conjupri 2.5 MG Oral Tablet	SY	2	These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019	20220503